Tachibana, T.; Matsuura, Y.; Ninomiya, H.; Ichinose, J.; Nakao, M.; Okumura, S.; Nishio, M.; Ikeda, N.; Mun, M.
Optimal Treatment Strategy for Oligo-Recurrence Lung Cancer Patients with Driver Mutations. Cancers 2024, 16, 464.
https://doi.org/10.3390/cancers16020464
AMA Style
Tachibana T, Matsuura Y, Ninomiya H, Ichinose J, Nakao M, Okumura S, Nishio M, Ikeda N, Mun M.
Optimal Treatment Strategy for Oligo-Recurrence Lung Cancer Patients with Driver Mutations. Cancers. 2024; 16(2):464.
https://doi.org/10.3390/cancers16020464
Chicago/Turabian Style
Tachibana, Taimei, Yosuke Matsuura, Hironori Ninomiya, Junji Ichinose, Masayuki Nakao, Sakae Okumura, Makoto Nishio, Norihiko Ikeda, and Mingyon Mun.
2024. "Optimal Treatment Strategy for Oligo-Recurrence Lung Cancer Patients with Driver Mutations" Cancers 16, no. 2: 464.
https://doi.org/10.3390/cancers16020464
APA Style
Tachibana, T., Matsuura, Y., Ninomiya, H., Ichinose, J., Nakao, M., Okumura, S., Nishio, M., Ikeda, N., & Mun, M.
(2024). Optimal Treatment Strategy for Oligo-Recurrence Lung Cancer Patients with Driver Mutations. Cancers, 16(2), 464.
https://doi.org/10.3390/cancers16020464